Kolon Life Science Inc.

₩12,550As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:102940Materials
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (18.68%)
Div yield 0.02%
ROE 7.12%
Chemicals
Beta (5Y) 0.29
PE TTM 5.223
TSR TTM (61.74%)
Mkt cap ₩164.3B
ROIC 2.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩15,641
24.63%
(66.05%)
Hold 8|6|1|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
312.63
318.53
343.34
342.98
27.76%
30.62%
27.08%
14.10%
Revenue₩B
7.921
7.930
8.149
8.408
1.60%
2.31%
6.76%
8.47%
Peers (US$121.1M)
Cap (US$)
PE
124.4M
17.80x
Capital
TTM
5Y
10Y
Leveragex
1.552
1.116
0.845
EBIT/Intx
5.219
0.341
0.338
Own earn%
(24.20)
184.00
178.76
Sh yield%
34.03
31.67
29.96
Owners
Insiders/Inst%
9.20
72.22
Short interest%
0.61
SBC / revenue%
5.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
12–17
$1 testx
0.2
Incr. ROIC%
7